Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 418

1.

Metformin Improves Neurologic Outcome Via AMP-Activated Protein Kinase-Mediated Autophagy Activation in a Rat Model of Cardiac Arrest and Resuscitation.

Zhu J, Liu K, Huang K, Gu Y, Hu Y, Pan S, Ji Z.

J Am Heart Assoc. 2018 Jun 12;7(12). pii: e008389. doi: 10.1161/JAHA.117.008389.

2.

Metformin Preconditioning of Human induced Pluripotent Stem Cell-derived Neural Stem Cells Promotes Their Engraftment and Improves Post-Stroke Regeneration and Recovery.

Ould-Brahim F, Sarma SN, Syal C, Lu KJ, Seegobin M, Carter A, Jeffers MS, Doré C, Stanford W, Corbett D, Wang J.

Stem Cells Dev. 2018 Jun 12. doi: 10.1089/scd.2018.0055. [Epub ahead of print]

PMID:
29893190
3.

Serum Brain-Derived Neurotrophic Factor is Related to Platelet Reactivity and Metformin Treatment in Adult Patients With Type 2 Diabetes Mellitus.

Eyileten C, Mirowska-Guzel D, Milanowski L, Zaremba M, Rosiak M, Cudna A, Kaplon-Cieslicka A, Opolski G, Filipiak KJ, Malek L, Postula M.

Can J Diabetes. 2018 Feb 3. pii: S1499-2671(17)30734-7. doi: 10.1016/j.jcjd.2018.01.014. [Epub ahead of print]

PMID:
29891331
4.

Place-based screening of mixtures of dominant emerging contaminants measured in Lake Michigan using zebrafish embryo gene expression assay.

Crago J, Klaper R.

Chemosphere. 2018 Feb;193:1226-1234. doi: 10.1016/j.chemosphere.2017.11.043. Epub 2017 Nov 10.

PMID:
29874752
5.

Combination of metformin and 9-cis retinoic acid increases apoptosis in C6 glioma stem-like cells.

Songthaveesin C, Sa-Nongdej W, Limboonreung T, Chongthammakun S.

Heliyon. 2018 May 31;4(5):e00638. doi: 10.1016/j.heliyon.2018.e00638. eCollection 2018 May.

6.

Role of apoptosis in the Post-traumatic stress disorder model-single prolonged stressed rats.

Jia Y, Han Y, Wang X, Han F.

Psychoneuroendocrinology. 2018 May 12;95:97-105. doi: 10.1016/j.psyneuen.2018.05.015. [Epub ahead of print] Review.

PMID:
29843020
7.

Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health.

O'Day E, Hosta-Rigau L, Oyarzún DA, Okano H, de Lorenzo V, von Kameke C, Alsafar H, Cao C, Chen GQ, Ji W, Roberts RJ, Ronaghi M, Yeung K, Zhang F, Lee SY.

Biotechnol J. 2018 May 24:e1800195. doi: 10.1002/biot.201800195. [Epub ahead of print] Review.

PMID:
29799175
8.

Comparative Efficacy and Acceptability of Anti-Diabetic Agents for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Network Meta-analysis.

Cao B, Rosenblat JD, Brietzke E, Park C, Lee Y, Musial N, Pan Z, Mansur RB, McIntyre RS.

Diabetes Obes Metab. 2018 May 23. doi: 10.1111/dom.13373. [Epub ahead of print]

PMID:
29790638
9.

Pre-Treatment with Metformin in Comparison with Post-Treatment Reduces Cerebral Ischemia Reperfusion Induced Injuries in Rats.

Karimipour M, Shojaei Zarghani S, Mohajer Milani M, Soraya H.

Bull Emerg Trauma. 2018 Apr;6(2):115-121. doi: 10.29252/beat-060205.

10.

Targeting Insulin for Alzheimer's Disease: Mechanisms, Status and Potential Directions.

Lee JH, Jahrling JB, Denner L, Dineley KT.

J Alzheimers Dis. 2018 Apr 27. doi: 10.3233/JAD-179923. [Epub ahead of print]

PMID:
29710715
11.

Neuroprotective effects of metformin on traumatic brain injury in rats associated with NF-κB and MAPK signaling pathway.

Tao L, Li D, Liu H, Jiang F, Xu Y, Cao Y, Gao R, Chen G.

Brain Res Bull. 2018 Apr 24;140:154-161. doi: 10.1016/j.brainresbull.2018.04.008. [Epub ahead of print]

PMID:
29698747
12.

Management of Glioblastoma Multiforme in a Patient Treated With Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up.

Elsakka AMA, Bary MA, Abdelzaher E, Elnaggar M, Kalamian M, Mukherjee P, Seyfried TN.

Front Nutr. 2018 Mar 29;5:20. doi: 10.3389/fnut.2018.00020. eCollection 2018.

13.

Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase/Extracellular-Regulated Kinase Pathways in an In Vitro Model of Graves' Orbitopathy.

Han YE, Hwang S, Kim JH, Byun JW, Yoon JS, Lee EJ.

Thyroid. 2018 Apr;28(4):528-536. doi: 10.1089/thy.2017.0338. Epub 2018 Mar 28.

PMID:
29589999
14.

Uterine progesterone signaling is a target for metformin therapy in PCOS-like rats.

Hu M, Zhang Y, Feng J, Xu X, Zhang J, Zhao W, Guo X, Li J, Vestin E, Cui P, Li X, Wu XK, Brännström M, Shao LR, Billig H.

J Endocrinol. 2018 May;237(2):123-137. doi: 10.1530/JOE-18-0086. Epub 2018 Mar 13.

PMID:
29535146
15.

Metformin ameliorates the age-related changes of d-galactose administration in ovariectomized mice.

Fatemi I, Heydari S, Kaeidi A, Shamsizadeh A, Hakimizadeh E, Khaluoi A, Allahtavakoli M.

Fundam Clin Pharmacol. 2018 Mar 7. doi: 10.1111/fcp.12364. [Epub ahead of print]

PMID:
29512848
16.

Centella asiatica ameliorates diabetes-induced stress in rat tissues via influences on antioxidants and inflammatory cytokines.

Masola B, Oguntibeju OO, Oyenihi AB.

Biomed Pharmacother. 2018 May;101:447-457. doi: 10.1016/j.biopha.2018.02.115. Epub 2018 Mar 22.

PMID:
29501767
17.

CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine.

Siskind D, Friend N, Russell A, McGrath JJ, Lim C, Patterson S, Flaws D, Stedman T, Moudgil V, Sardinha S, Suetani S, Kisely S, Winckel K, Baker A.

BMJ Open. 2018 Mar 2;8(3):e021000. doi: 10.1136/bmjopen-2017-021000.

18.

Combination of Metformin and Lifestyle Intervention for Antipsychotic-Related Weight Gain: A Meta-Analysis of Randomized Controlled Trials.

Zheng W, Zhang QE, Cai DB, Yang XH, Ungvari GS, Ng CH, Wu RR, Xiang YT.

Pharmacopsychiatry. 2018 Feb 27. doi: 10.1055/s-0044-101466. [Epub ahead of print]

PMID:
29486513
19.

Evaluation of the neonatal streptozotocin model of diabetes in rats: Evidence for a model of neuropathic pain.

Barragán-Iglesias P, Oidor-Chan VH, Loeza-Alcocer E, Pineda-Farias JB, Velazquez-Lagunas I, Salinas-Abarca AB, Hong E, Sánchez-Mendoza A, Delgado-Lezama R, Price TJ, Granados-Soto V.

Pharmacol Rep. 2018 Apr;70(2):294-303. doi: 10.1016/j.pharep.2017.09.002. Epub 2017 Sep 14.

PMID:
29477037
20.

Metformin inhibits TGF-β1-induced epithelial-to-mesenchymal transition-like process and stem-like properties in GBM via AKT/mTOR/ZEB1 pathway.

Song Y, Chen Y, Li Y, Lyu X, Cui J, Cheng Y, Zhao L, Zhao G.

Oncotarget. 2017 Dec 15;9(6):7023-7035. doi: 10.18632/oncotarget.23317. eCollection 2018 Jan 23.

Supplemental Content

Loading ...
Support Center